scholarly journals Phonetics exercises using the Alvin experiment-control software

2014 ◽  
Vol 135 (4) ◽  
pp. 2196-2196 ◽  
Author(s):  
James Hillenbrand
2015 ◽  
Vol 58 (2) ◽  
pp. 171-184 ◽  
Author(s):  
James M. Hillenbrand ◽  
Robert T. Gayvert ◽  
Michael J. Clark

Purpose Exercises are described that were designed to provide practice in phonetic transcription for students taking an introductory phonetics course. The goal was to allow instructors to offload much of the drill that would otherwise need to be covered in class or handled with paper-and-pencil tasks using text rather than speech as input. Method The exercises were developed using Alvin, a general-purpose software package for experiment design and control. The simplest exercises help students learn sound–symbol associations. For example, a vowel-transcription exercise presents listeners with consonant–vowel–consonant syllables on each trial; students are asked to choose among buttons labeled with phonetic symbols for 12 vowels. Several word-transcription exercises are included in which students hear a word and are asked to enter a phonetic transcription. Immediate feedback is provided for all of the exercises. An explanation of the methods that are used to create exercises is provided. Results Although no formal evaluation was conducted, comments on course evaluations suggest that most students found the exercises to be useful. Conclusions Exercises were developed for use in an introductory phonetics course. The exercises can be used in their current form, they can be modified to suit individual needs, or new exercises can be developed.


2019 ◽  
Vol 64 (5) ◽  
pp. 1188-1198 ◽  
Author(s):  
S. Turriziani ◽  
J. Ekelund ◽  
K. Tsuno ◽  
M. Casolino ◽  
T. Ebisuzaki

2007 ◽  
Vol 39 (3) ◽  
pp. 689-693 ◽  
Author(s):  
Helena Matute ◽  
Miguel A. Vadillo ◽  
Raúl Bárcena

2021 ◽  
Author(s):  
Florian Krause ◽  
Oliver Lindemann

A recent study tested the timing accuracy of several software solutions to implement computer-based experiments (Bridges et al. 2020). We discuss some conceptual and implementation issues in an attempt to bring more general awareness to what implementing timing-accurate experiments crucially relies on: (1) familiarizing oneself with the basic principles of stimulus presentation as well as the specifics of the used experiment control software, and (2) understanding that timing accuracy estimates should never be understood as a hard promise to simply rely on without additional verification in a specific lab setting. We believe that the raised issues should be considered in a discussion on how software for computer-based experiments should be tested.


2014 ◽  
Vol 608-609 ◽  
pp. 651-655
Author(s):  
Zhong Tang ◽  
Yue Xie

The control system for Inertia Confinement Fusion (ICF) experiment facility is based on a scalable software framework and can implement centralized control of thousands of devices and roboticized experiment processes. Experiment Control Software Framework (ECSF) is the control software framework specially for large-scale experiment facility, colligating advantages of CORBA and Agent. By the reuse at the system level, control software can be fleetly constructed. Software device Agent based on OOD is the base of framework. Centralized manager and common module implement events, alerts, reservations, logging, data archive, flow and arithmetic management. Several connection managements are also provided for the member of the framework. Taking patch energy subsystem as an example, the instantiation of the framework is introduced to validate the feasibility and validity of ECSF.


Author(s):  
James Kapinski ◽  
Alexandre Donze ◽  
Flavio Lerda ◽  
Hitashyam Maka ◽  
Edmund Clarke ◽  
...  

Author(s):  
М.Н. Карпова ◽  
Л.В. Кузнецова ◽  
Н.Ю. Клишина ◽  
Л.А. Ветрилэ

Цель исследования. На 2 моделях острых генерализованных судорог (ОГС), вызванных конвульсантом пентилентетразолом (ПТЗ), изучить эффективность сочетанного применения ноотропа цитиколина - препарата с противосудорожным действием, нейрорегенеративной, нейропротекторной активностью и антител (АТ) к глутамату, обладающих противосудорожной активностью. Методика. Эксперименты выполнены на мышах-самцах линии C57Bl/6 (n = 87) массой 22-28 г. Эффективность сочетанного применения цитиколина и АТ к глутамату изучали на двух моделях ОГС. Выполнено 2 серии экспериментов. В 1-й серии ОГС вызывали внутривенным введением 1% раствора ПТЗ со скоростью 0,01 мл/с. Для изучения эффективности сочетанного применения препаратов определяли минимальное противосудорожное действие цитиколина (Цераксон, «Nicomed Ferrer Internaсional, S.A.») и АТ к глутамату при их внутрибрюшинном введении. С этой целью цитиколин вводили в дозах 500 и 300 мг/кг за 1 ч до введения ПТЗ, АТ к глутамату - в дозах 5 и 2,5 мг/кг за 1 ч 30 мин до введения ПТЗ. АТ к глутамату получали путем гипериммунизации кроликов соответствующим конъюгированным антигеном. Во 2-й серии ОГС вызывали подкожным введением ПТЗ в дозе 85 мг/кг. Для изучения эффективности сочетанного действия изучаемых препаратов последние вводили в минимально действующих дозах, установленных в 1-й серии экспериментов. Контролем во всех сериях опытов служили животные, которым вводили в аналогичных условиях и в том же объеме физиологический раствор. Результаты. Показано, что сочетанное применение цитиколина и АТ к глутамату в минимально действующих дозах (300 и 2,5 мг/кг соответственно) при моделировании ОГС не вызывало повышения судорожной активности мозга и усиления противосудорожных свойств препаратов. Заключение. Cочетанное применение цитиколина и АТ к глутамату в минимально действующих дозах не вызывало повышения судорожной активности мозга, что свидетельствует о безопасности совместного применения препаратов. Проведенное исследование может служить также экспериментальным обоснованием возможности использования сочетанного применения данных препаратов при судорогах с целью замедления прогрессирования нейродегенеративных процессов и благоприятного влияния на когнитивные функции. Aim. To study the effectivity of a combination of citicoline, a nootropic substance with neuroregenerative, neuroprotective, and anticonvulsant actions, and glutamate antibodies (АB) with an anticonvulsant action in two models of acute generalized convulsions (AGC) caused by the convulsant pentylenetetrazole (PTZ). Methods. Experiments were conducted on C57Bl/6 mice (n = 87) weighing 22-28 g. Effects of combined citicoline and glutamate АB were studied on two models of AGС. In the first series of experiments, AGС was induced by intravenous infusion of a 1% PTZ solution at 0.01 ml/sec. In the second series, AGС was induced by a subcutaneous injection of PTZ 85 mg/kg. To evaluate efficacy of the drug combination minimum intraperitoneal anticonvulsant doses of citicoline (Tserakson, Nicomed Ferrer Internacional, S.A.) and glutamate АB were determined. To this purpose, citicoline was administered at 500 and 300 mg/kg 1 h prior to PTZ, and glutamate АB was administered at 5 and 2.5 mg/kg 90 min prior to PTZ. Glutamate АB was obtained by hyperimmunization of rabbits with a respective conjugated antigen. In the second series of experiments, AGС was induced by a subcutaneous injection of PTZ 85 mg/kg. To evaluate the effect of the drug combination, the drugs were administered at the minimum effective doses determined in the first series of experiment. Control animals were injected with the same volume of saline in the same experimental conditions. Results. The combination of citicoline and glutamate AB used at minimum effective doses of 300 and 2.5 mg/kg, respectively, did not increase the seizure activity in the brain and enhanced anticonvulsant properties of the drugs in two models of AGС. Conclusion. The combination of citicoline and glutamate AT at minimum effective doses did not increase the convulsive activity in the brain, which supported safety of the drug combination. Besides, this study can serve as an experimental justification for using the drug combination in convulsions to favorably influence cognitive functions and slow progression of neurodegenerative processes.


Sign in / Sign up

Export Citation Format

Share Document